Dilaforette is Granted SEK 2.8M for Development of Sevuparin for the Treatment of Severe Malaria  
11/2/2012 2:31:59 PM

STOCKHOLM – November 2, 2012. Dilaforette announces today that it has been granted SEK 2.85m from the Swedish Governmental Agency for Innovation Systems, Vinnova, for the development of sevuparin, a new potential treatment for severe malaria.